DENIS R. ST. LAURENT,GAN WANG,JEFFREY LEE ROMINE,JOHN A. BENDER,JOHN F. KADOW,LAWRENCE B. SNYDER,MAKONEN BELEMA,NICHOLAS A. MEANWELL,NINGNING XU,OMAR D. LOPEZ,PIYASENA HEWAWASAM,VAN N. NGUYEN
申请号：
BRPI1013393
公开号：
BRPI1013393A2
申请日:
2010.03.24
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
